Medincell SA MEDCL
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
MedinCell S.A. is a clinical-stage biopharmaceutical company specializing in the development of long-acting injectable therapies to improve treatment adherence and accessibility worldwide. Leveraging its proprietary BEPO® technology, a biodegradable polymer-based platform for sustained drug release, the company creates…
SectorHealthcare
ExchangeXPAR
IndustryBiotechnology
CountryFrance
Employees131
TickerMEDCL
Statistics
Market Cap$947.0M
Revenue (TTM)$30.8M
Net Income—
Net Margin—
EPS—
P/E-45.19
P/S30.79
P/B—
EV/EBITDA-98.34
ROE112.7%
Dividend Yield—
Price$28.61
Data: Twelve Data · Revenue = mcap / P/S